Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis

Authors: Hanssa Summah, Li-Li Tao, Ying-Gang Zhu, Hong-Ni Jiang, Jie-Ming Qu

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Pleural infection is a common clinical problem. Its successful treatment depends on rapid diagnosis and early initiation of antibiotics. The measurement of soluble triggering receptor expressed in myeloid cells-1 (sTREM-1) level in pleural effusions has proven to be a valuable diagnostic tool for differentiating bacterial effusions from effusions of other etiologies. Herein, we performed a meta-analysis to assess the accuracy of pleural fluid sTREM-1 in the diagnosis of bacterial infection.

Methods

We searched Web of Knowledge and Medline from 1990 through March 2011 for studies reporting diagnostic accuracy data regarding the use of sTREM-1 in the diagnosis of bacterial pleural effusions. Pooled sensitivity and specificity and summary measures of accuracy and Q* were calculated.

Results

Overall, the sensitivity of sTREM-1was 78% (95% CI: 72%-83%); the specificity was 84% (95% CI: 80%-87%); the positive likelihood ratio was 6.0 (95% CI: 3.3-10.7); and the negative likelihood ratio was 0.22 (95% CI: 0.12-0.40). The area under the SROC curve for sTREM-1 was 0.92. Statistical heterogeneity and inconsistency were found for sensitivity (p = 0.015, χ2 = 15.73, I2 = 61.9%), specificity (p = 0.000, χ2 = 29.90, I2 = 79.9%), positive likelihood ratio (p = 0.000, χ2 = 33.09, I2 = 81.9%), negative likelihood ratio (p = 0.008, χ2 = 17.25, I2 = 65.2%), and diagnostic odds ratio (p = 0.000, χ2 = 28.49, I2 = 78.9%). A meta-regression analysis performed showed that the Quality Assessment of Diagnostic Accuracy Studies score (p = 0.3245; RDOR, 4.34; 95% CI, 0.11 to 164.01), the Standards for Reporting of Diagnostic Accuracy score (p = 0.3331; RDOR, 1.70; 95% CI, 0.44 to 6.52), lack of blinding (p = 0.7439; RDOR, 0.60; 95% CI, 0.01 to 33.80), and whether the studies were prospective or retrospective studies (p = 0.2068; RDOR, 7.44; 95% CI, 0.18 to 301.17) did not affect the test accuracy. A funnel plot for publication bias suggested a remarkable trend of publication bias.

Conclusions

Our findings suggest that sTREM-1 has a good diagnostic accuracy and may provide a useful adjunctive tool for the diagnosis of bacterial pleural effusions. However, further studies are needed in order to identify any differences in the diagnostic performance of sTREM-1 of parapneumonic effusions and empyemas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rahman NM, Davies RJO: Effusions from infections: Parapneumonic effusion and empyema. Textbook of Pleural Disease. Edited by: Light RW, Lee YCG. 2008, London: Hodder & Stoughton, 341-367. 2CrossRef Rahman NM, Davies RJO: Effusions from infections: Parapneumonic effusion and empyema. Textbook of Pleural Disease. Edited by: Light RW, Lee YCG. 2008, London: Hodder & Stoughton, 341-367. 2CrossRef
2.
go back to reference Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000, 164: 4991-4995.CrossRefPubMed Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000, 164: 4991-4995.CrossRefPubMed
3.
go back to reference Porcel JM: Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med. 2010, 16 (4): 357-361. 10.1097/MCP.0b013e328338a108.CrossRefPubMed Porcel JM: Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med. 2010, 16 (4): 357-361. 10.1097/MCP.0b013e328338a108.CrossRefPubMed
4.
go back to reference Soto GJ: Diagnostic strategies for nosocomial pneumonia. Curr Opin Pulm Med. 2007, 13 (3): 186-191. 10.1097/MCP.0b013e3280ef6941.CrossRefPubMed Soto GJ: Diagnostic strategies for nosocomial pneumonia. Curr Opin Pulm Med. 2007, 13 (3): 186-191. 10.1097/MCP.0b013e3280ef6941.CrossRefPubMed
5.
go back to reference Lourens NA, Bösenberg LH, Tintinger GR, Ker J, Fickl H, Sharp C, Van Zyl M, Anderson R: Soluble Triggering Receptor Expressed on Myeloid Cells in Patients With Suspected Meningitis, Peritonitis, or Pleuritis. Infectious Diseases in Clinical Practice. 2008, 16 (3): 157-162. 10.1097/IPC.0b013e318167652d.CrossRef Lourens NA, Bösenberg LH, Tintinger GR, Ker J, Fickl H, Sharp C, Van Zyl M, Anderson R: Soluble Triggering Receptor Expressed on Myeloid Cells in Patients With Suspected Meningitis, Peritonitis, or Pleuritis. Infectious Diseases in Clinical Practice. 2008, 16 (3): 157-162. 10.1097/IPC.0b013e318167652d.CrossRef
6.
go back to reference Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004, 350 (5): 451-458. 10.1056/NEJMoa031544.CrossRefPubMed Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004, 350 (5): 451-458. 10.1056/NEJMoa031544.CrossRefPubMed
7.
go back to reference McGrath EE, Warriner D, Anderson PB: The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion. Respir Med. 2010, 104 (8): 1092-1100. 10.1016/j.rmed.2010.03.008.CrossRefPubMed McGrath EE, Warriner D, Anderson PB: The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion. Respir Med. 2010, 104 (8): 1092-1100. 10.1016/j.rmed.2010.03.008.CrossRefPubMed
8.
go back to reference Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25-10.1186/1471-2288-3-25.CrossRefPubMedPubMedCentral Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25-10.1186/1471-2288-3-25.CrossRefPubMedPubMedCentral
9.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003, 49 (1): 1-6. 10.1373/49.1.1.CrossRefPubMed Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003, 49 (1): 1-6. 10.1373/49.1.1.CrossRefPubMed
10.
go back to reference Halkin A, Reichman J, Schwaber M, Paltiel O, Brezis M: Likelihood ratios: getting diagnostic testing into perspective. QJM. 1998, 91 (4): 247-258. 10.1093/qjmed/91.4.247.CrossRefPubMed Halkin A, Reichman J, Schwaber M, Paltiel O, Brezis M: Likelihood ratios: getting diagnostic testing into perspective. QJM. 1998, 91 (4): 247-258. 10.1093/qjmed/91.4.247.CrossRefPubMed
11.
go back to reference Moses LE, Shapiro D, Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993, 12 (14): 1293-1316. 10.1002/sim.4780121403.CrossRefPubMed Moses LE, Shapiro D, Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993, 12 (14): 1293-1316. 10.1002/sim.4780121403.CrossRefPubMed
12.
go back to reference Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21 (11): 1539-1558. 10.1002/sim.1186.CrossRefPubMed Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21 (11): 1539-1558. 10.1002/sim.1186.CrossRefPubMed
13.
go back to reference Eggar M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.CrossRef Eggar M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.CrossRef
14.
go back to reference Chan MC, Chang KM, Chao WC, Lin LY, Kuo BI, Hsu JY, Wu CL: Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology. 2007, 12 (3): 333-338. 10.1111/j.1440-1843.2007.01056.x.CrossRefPubMed Chan MC, Chang KM, Chao WC, Lin LY, Kuo BI, Hsu JY, Wu CL: Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology. 2007, 12 (3): 333-338. 10.1111/j.1440-1843.2007.01056.x.CrossRefPubMed
15.
go back to reference Huang LY, Shi HZ, Liang QL, Wu YB, Qin XJ, Chen YQ: Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J (Engl). 2008, 121 (17): 1656-1661. Huang LY, Shi HZ, Liang QL, Wu YB, Qin XJ, Chen YQ: Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J (Engl). 2008, 121 (17): 1656-1661.
16.
go back to reference Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H: Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg. 2009, 87 (1): 251-254. 10.1016/j.athoracsur.2008.09.047.CrossRefPubMed Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H: Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg. 2009, 87 (1): 251-254. 10.1016/j.athoracsur.2008.09.047.CrossRefPubMed
17.
go back to reference Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A, Esquerda A: Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 2009, 34 (6): 1383-1389. 10.1183/09031936.00197208.CrossRefPubMed Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A, Esquerda A: Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 2009, 34 (6): 1383-1389. 10.1183/09031936.00197208.CrossRefPubMed
18.
go back to reference Determann RM, Achouiti AA, El Solh AA, Bresser P, Vijfhuizen J, Spronk PE, Schultz MJ: Infectious pleural effusions can be identified by sTREM-1 levels. Respir Med. 2010, 104 (2): 310-315. 10.1016/j.rmed.2009.09.008.CrossRefPubMed Determann RM, Achouiti AA, El Solh AA, Bresser P, Vijfhuizen J, Spronk PE, Schultz MJ: Infectious pleural effusions can be identified by sTREM-1 levels. Respir Med. 2010, 104 (2): 310-315. 10.1016/j.rmed.2009.09.008.CrossRefPubMed
19.
go back to reference Kim JH, Park EY, Kim WH, Park W, Jeong HC, Lee JH, Kim EK: Soluble triggering receptor expressed on myeloid cells-1: role in the diagnosis of pleural effusions. Tuberc Respir Dis. 2007, 62: 290-298. 10.4046/trd.2007.62.4.290.CrossRef Kim JH, Park EY, Kim WH, Park W, Jeong HC, Lee JH, Kim EK: Soluble triggering receptor expressed on myeloid cells-1: role in the diagnosis of pleural effusions. Tuberc Respir Dis. 2007, 62: 290-298. 10.4046/trd.2007.62.4.290.CrossRef
20.
go back to reference Yun SS, Jin HL, Eun MC, Jung Hyun Chang: Diagnostic utility of pleural fluid soluble triggering receptor expressed on myeloid cells 1 protein in patients with exudative pleural effusion. Tuberc Respir Dis 2. 2007, 62: 499-505. 10.4046/trd.2007.62.6.499.CrossRef Yun SS, Jin HL, Eun MC, Jung Hyun Chang: Diagnostic utility of pleural fluid soluble triggering receptor expressed on myeloid cells 1 protein in patients with exudative pleural effusion. Tuberc Respir Dis 2. 2007, 62: 499-505. 10.4046/trd.2007.62.6.499.CrossRef
21.
23.
go back to reference Gibot S, Kolopp-Sarda M-N, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Annals of Internal Medicine. 2004, 141 (1): 9-15.CrossRefPubMed Gibot S, Kolopp-Sarda M-N, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Annals of Internal Medicine. 2004, 141 (1): 9-15.CrossRefPubMed
24.
go back to reference Gibot S: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis. Seminars in Respiratory and Critical Care Medicine. 2006, 27 (1): 29-33. 10.1055/s-2006-933671.CrossRefPubMed Gibot S: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis. Seminars in Respiratory and Critical Care Medicine. 2006, 27 (1): 29-33. 10.1055/s-2006-933671.CrossRefPubMed
25.
go back to reference Tejera A, Santolaria F, Diez ML, Alemán-Valls MR, González-Reimers E, Martínez-Riera A, Milena-Abril A: Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine. 2007, 38 (3): 117-23. 10.1016/j.cyto.2007.05.002.CrossRefPubMed Tejera A, Santolaria F, Diez ML, Alemán-Valls MR, González-Reimers E, Martínez-Riera A, Milena-Abril A: Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine. 2007, 38 (3): 117-23. 10.1016/j.cyto.2007.05.002.CrossRefPubMed
26.
go back to reference El Solh AA, Akinnusi ME, Peter M, Berim I, Schultz MJ, Pineda L: Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med. 2008, 34 (6): 981-984. 10.1007/s00134-008-1088-6.CrossRef El Solh AA, Akinnusi ME, Peter M, Berim I, Schultz MJ, Pineda L: Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med. 2008, 34 (6): 981-984. 10.1007/s00134-008-1088-6.CrossRef
27.
go back to reference Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J. 2004, 24 (2): 247-250. 10.1183/09031936.04.00014204.CrossRefPubMed Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J. 2004, 24 (2): 247-250. 10.1183/09031936.04.00014204.CrossRefPubMed
28.
go back to reference Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT: Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med. 2007, 101 (5): 903-909. 10.1016/j.rmed.2006.09.021.CrossRefPubMed Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT: Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med. 2007, 101 (5): 903-909. 10.1016/j.rmed.2006.09.021.CrossRefPubMed
29.
go back to reference Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003, 56: 1129-1135. 10.1016/S0895-4356(03)00177-X.CrossRefPubMed Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003, 56: 1129-1135. 10.1016/S0895-4356(03)00177-X.CrossRefPubMed
30.
go back to reference Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001, 410 (6832): 1103-1107. 10.1038/35074114.CrossRefPubMed Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001, 410 (6832): 1103-1107. 10.1038/35074114.CrossRefPubMed
31.
go back to reference Petitti DB: Approaches to heterogeneity in meta-analysis. Stat Med. 2001, 20: 3625-3633. 10.1002/sim.1091.CrossRefPubMed Petitti DB: Approaches to heterogeneity in meta-analysis. Stat Med. 2001, 20: 3625-3633. 10.1002/sim.1091.CrossRefPubMed
32.
go back to reference Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B: Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005, 33 (4): 792-796. 10.1097/01.CCM.0000159089.16462.4A.CrossRefPubMed Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B: Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005, 33 (4): 792-796. 10.1097/01.CCM.0000159089.16462.4A.CrossRefPubMed
33.
go back to reference Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-1101. 10.2307/2533446.CrossRefPubMed Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-1101. 10.2307/2533446.CrossRefPubMed
34.
go back to reference Sterne JA, Harbord RM: Funnel plots in meta-analysis. The Stata Journal. 2004, 4 (2): 127-141. Sterne JA, Harbord RM: Funnel plots in meta-analysis. The Stata Journal. 2004, 4 (2): 127-141.
Metadata
Title
Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis
Authors
Hanssa Summah
Li-Li Tao
Ying-Gang Zhu
Hong-Ni Jiang
Jie-Ming Qu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-280

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.